Pilot study of intravenous immunoglobulin in HIV-associated myelopathy

AIDS Patient Care and STDs

Volumn 23, Issue 2, 2009, Pages 75-78

  Cikurel, Katia ^a   Schiff, Lauren ^a   Simpson, David M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; IMMUNOGLOBULIN; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; BACKACHE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG INFUSION; DRUG USE; FEMALE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INJECTION SITE SWELLING; MALE; MEDICAL RESEARCH; PILOT STUDY; SCORING SYSTEM; SIDE EFFECT; SORE THROAT; SPINAL CORD DISEASE; UREA NITROGEN BLOOD LEVEL;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PILOT PROJECTS; SPINAL CORD DISEASES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 60749116414     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2008.0018     Document Type: Article

References (14)

1. Artigas J, Grosse G, Niedobitek F. Vacuolar myelopathy in AIDS: A morphological analysis. Pathol Res Pract 1990;186:228-237.
2. Petito CK, Navia BA, Cho E-S et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with Acquired Immune Deficiency Syndrome. N Engl J Med 1985;312:874-879
3. Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: An autopsy-based case-control study. Neurology 1994;44:2159.
4. Aboulafia DM, Taylor L. Vacuolar myelopathy and vacuolar cerebellar leukoencephalopathy: A late complication of AIDS after highly active antiretroviral therapy-induced immune reconstitution. AIDS Patient Care STDs 2002;12:579-584.
5. Staudinger R, Henry K. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology 2000;54:267-268.
6. Di Rocco A, Geraci A, Tagliati M. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology 2000;55:456.
7. Tan SV, Guiloff RJ, Scaravilli F. AIDS associated Vacuolar myelopathy. A morphometric study. Brain 1995;118:1247-1261.
8. Rottnek M, Di Rocco A, Laudier D, Morgello S. Axonal damage is a late component of vacuolar myelopathy. Neurology 1995;58:479-481.
9. Di Rocco, A, Wener P, Bottiglieri, et al. Treatment of AIDS-associated myelopathy with l-methionine: A placebo-controlled study. Neurology 1997;63:1270-1275.
10. Malamut RI, Leopold N, Parry GL. The treatment of HIV-chronic inflammatory demyelinating polyneuropathy (HIV-CIDP) with intravenous immunoglobulin (IVIg). Neurology 1992;42(Suppl 3)335.
11. Johnson RT, McArthur JC. Myelopathies and retroviral infections. Ann Neurol 1987;21:113-116.
12. Kuroda Y, Takashima H, Ikeda A, et al. Treatment of HTLV-1-associated myelopathy with high-dose intravenous gammaglobulin. J Neurol 1991;48:312-314.
13. Hillel AD, Miller RM, Yorkston K, et al. Amyotrophic lateral sclerosis severity scale. Neuroepidemiology 1989;8:142-150.
14. Banks LT, Geraci A, Liu M, Gobold G, et al. A natural history of HIV myelopathy in the HAART era [Abstract PO6.037]. Neurology 2002;(Suppl 3):A441.